Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Boston, Massachusetts
- Most recent report
- 10-Q, filed Nov 4, 2026
- Incorporated
- Delaware
- Filings on record
- 253 filings
- On EDGAR
- CIK 2012593
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
Financials 8 of 10
News 8 of 24
Prospectuses and Registrations 8 of 20
- 424B5 Prospectus supplement for an offering Oct 30, 2026
- 424B5 Prospectus supplement for an offering Oct 30, 2026
- FWP Free writing prospectus Oct 28, 2026
- FWP Free writing prospectus Oct 28, 2026
- FWP Free writing prospectus Oct 28, 2026
- FWP Free writing prospectus Oct 28, 2026
- 424B5 Prospectus supplement for an offering Oct 27, 2026
- 424B5 Prospectus supplement for an offering Oct 27, 2026
Proxies 4
Ownership 8 of 170
- 4 Insider reported a trade Nov 3, 2026
- 4 Insider reported a trade Oct 30, 2026
- 4 Insider reported a trade Oct 23, 2026
- 4 Insider reported a trade Oct 23, 2026
- 4 Insider reported a trade Oct 22, 2026
- 4 Insider reported a trade Oct 22, 2026
- 4 Insider reported a trade Oct 22, 2026
- 4 Insider reported a trade Oct 22, 2026
Other 8 of 25
- 305B2 Oct 29, 2026
- ARS Annual report sent to shareholders Apr 23, 2026
- EFFECT Notice that a registration became effective Jul 9, 2025
- EFFECT Notice that a registration became effective Jul 9, 2025
- CORRESP Reply to SEC staff Jul 7, 2025
- CORRESP Reply to SEC staff Jul 7, 2025
- UPLOAD Comment letter from SEC staff Jul 7, 2025
- UPLOAD Comment letter from SEC staff Jul 7, 2025
Everything here comes from Rapport Therapeutics, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.